2021-05-12T13:47:06-05:00 2020-06-30 PricewaterhouseCoopers LLP 101 SEAPORT BLVD SUITE 500 BOSTON MA 02210 990 2019-07-01 830561457 COUNT ME IN INC % JOHN TRAVIA COUN 6177147929 415 MAIN STREET CAMBRIDGE MA 02142 JOHN TRAVIA TREASURER 2021-05-11 true Paul J Tanis P01441612 6175305000 2019 2022-09-23 18:48:47Z JOHN TRAVIA 415 MAIN STREET CAMBRIDGE MA 02142 10010694 false X HTTP://JOINCOUNTMEIN.ORG X 2018 MA SEE SCHEDULE O. 9 9 0 0 0 0 0 10000500 0 0 0 10194 0 0 0 10010694 0 0 0 0 0 1169088 0 0 0 0 2922001 0 4091089 0 5919605 0 10002307 0 4082702 0 5919605 X THE MISSION OF CMI INC. IS TO TRANSFORM CANCER CARE AND OUTCOMES BY EMPOWERING CANCER PATIENTS TO ACCELERATE BIOMEDICAL RESEARCH BY SHARING THEIR SAMPLES, THEIR CLINICAL INFORMATION, AND THEIR VOICES. true false 3580741 0 0 SEE SCHEDULE O 3580741 true true false false false false false false false false false false false false true false true false false false false false false false false false false false false false false false false false false false false false false false false false false false false false false true 0 0 0 false false false false false false false false false false false false X 9 9 true false false false true true false true true false false true true true true true true false false false MA X X JOHN TRAVIA 6177147729 415 MAIN STREET CAMBRIDGE MA 02142 X Nikhil Wagle Director/President 10.0 0.0 X X 0 0 0 Jesse Souweine TREASURER (UNT 4/20)/DIRECTOR 1.0 0.0 X X 0 0 0 Matt Bettonville Director 1.0 0.0 X 0 0 0 Reed Jobs Director 1.0 0.0 X 0 0 0 Eric Lander Director 1.0 0.0 X 0 0 0 LAURIE GLIMCHER DIRECTOR (BEG 7/19) 1.0 0.0 X 0 0 0 ANDREW FORREST DIRECTOR (BEG 9/19) 1.0 0.0 X 0 0 0 CINDY CITRONE DIRECTOR (BEG 4/20) 1.0 0.0 X 0 0 0 GREG SIMON DIRECTOR 1.0 0.0 X 0 0 0 Kristen Zarrelli CLERK 3.0 0.0 X 0 0 0 JOHN TRAVIA TREASURER (BEG 4/20) 2.0 0.0 X 0 0 0 0 0 0 0 false false false 0 10000500 10000500 0 10194 10194 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10010694 10194 0 0 0 0 0 0 937924 937924 0 231164 231164 0 0 0 10000 10000 0 0 0 23976 15589 8387 162 162 4302 4302 36025 36025 0 335845 335845 16908 16908 0 10233 10233 0 0 0 0 MATERIALS AND SERVICES 2484550 1992589 491961 0 4091089 3580741 510348 0 0 10002307 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 10002307 0 10000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 4072702 0 4082702 X 0 5919605 0 0 0 5919605 0 10002307 5919605 X false true X true false X 0 0 0 0 10000500 10000500 0 0 0 0 0 0 0 0 10000500 10000500 9799786 200714 10194 10194 0 0 0 0 10010694 0 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 DUE TO BROAD INSTITUTE 4072702 4072702 10010694 10010694 10010694 4091089 4091089 4091089 ORGANIZATION'S MISSION FORM 990, PART I, LINE 1 THE MISSION OF COUNT ME IN IS TO TRANSFORM CANCER CARE AND OUTCOMES BY EMPOWERING CANCER PATIENTS TO ACCELERATE BIOMEDICAL RESEARCH BY SHARING THEIR SAMPLES, THEIR CLINICAL INFORMATION, AND THEIR VOICES. STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FORM 990, PART III, LINE 2 The organization did not report program service accomplishments for tax years 2017 and 2018, the organization's first years of existence. The program services described in Part III, Line 4a of Form 990 initially began in tax year 2019. FORM 990, PART III, LINE 4A Count Me In has launched six projects to date, spanning rare, common and pediatric cancers: The Metastatic Breast Cancer Project (2015), The Angiosarcoma Project (2017), The Metastatic Prostate Cancer Project (2018), The Esophageal and Stomach Cancer Project (2018), the Brain Cancer Project (2019) and the Osteosarcoma Project (2020). Two new projects have been initiated and are being built: the Leiomyosarcoma Project and the Colorectal Cancer Project. These will both be launched in 2021. Our capabilities and infrastructure include the ability to: (a) engage and consent patients remotely; (b) collect longitudinal patient-reported data; (c) ship and receive saliva and blood collection kits from patients; (d) request and receive medical records and tumor tissues from institutions across the U.S.; (e) abstract clinical data from medical records and patient-reported data; (f) perform genomic characterization (Whole Exome Sequencing (WES), RNAseq, Whole Genome Sequencing (WGS)) on tumor, saliva, and plasma-derived cell-free DNA; (g) analyze and interpret clinically annotated somatic and germline genomic data; and (h) share all de-identified data acquired or generated in the project regularly- pre-publication and without restrictions-via public/accessible databases (cBioPortal, dbGaP, NCI Genomic Data Commons). Across the six projects, we have registered over 8,000 patients from all 50 U.S. states and Canada - including both adult and pediatric participants. Over 5,000 patients from over 1,700 different institutions have enrolled in the study, providing their consent to share their medical records, tumor samples, and saliva samples, as well as to have comprehensive genomic analysis performed on their samples. We have collected more than 2,300 medical records, 3,000 saliva samples, 1,700 blood samples, and 1,100 tumors specimens from participants. To date, Count Me In has publicly shared data from the MBCproject, ASCproject, and MPCproject on several platforms, including the Genomic Data Commons, dbGaP, cBioPortal and through our own data browsers. This publicly available de-identified data has been cited in over 40 peer reviewed publications to date by researchers independent of the Count Me In team. We have also seen a marked increase in interest from the research community in accessing our data over the past year and we have been made aware of multiple studies that are in development or under review at scientific journals. RELATIONSHIPS AMONG FORM 990 PART VI, LINE 2 NIKHIL WAGLE AND LAURIE GLIMCHER HAVE A BUSINESS RELATIONSHIP. NIKHIL WAGLE IS DIRECTOR AND PRESIDENT AT CMI AND LAURIE GLIMCHER IS A DIRECTOR AT CMI. REED JOBS AND MATT BETTONVILLE HAVE A BUSINESS RELATIONSHIP. BOTH ARE DIRECTORS AT CMI. ERIC LANDER, JESSE SOUWEINE, JOHN TRAVIA AND KRISTEN ZARRELLI HAVE A BUSINESS RELATIONSHIP. ERIC LANDER AND JESSE SOUWEINE ARE DIRECTORS AT CMI AND JOHN TRAVIA AND KRISTEN ZARRELLI ARE OFFICERS OF CMI. MEMBERS FORM 990 PART VI, LINE 6 THE MEMBERS OF COUNT ME IN INC. CONSIST OF THE BROAD INSTITUTE, INC., EMERSON COLLECTIVE LLC, DANA FARBER CANCER INSTITUTE, INC. AND BIDEN CANCER INITIATIVE, INC. DECISIONS OF THE GOVERNING BODY SUBJECT TO APPROVAL BY MEMBERS FORM 990 PART VI, LINE 7A AND 7B MEMBERS EXERCISE ALL POWERS CONSISTENT WITH THE ACTIVITIES AND AFFAIRS OF COUNT ME IN. THE MEMBERS HAVE ALL POWERS AND RIGHTS AS ARE VESTED IN THEM BY LAW, THE ARTICLES OF ORGANIZATION AND THE BY-LAWS, WHICH INCLUDE AMENDMENTS TO THE BY-LAWS AND ARTICLES OF INCORPORATION, THE ELECTION OR REPLACEMENT OF DIRECTORS AND DISSOLUTION OF THE ORGANIZATION. THE MEMBERS SHALL HOLD AN ANNUAL MEETING FOR ELECTION OF DIRECTORS AND FOR THE CONDUCT OF SUCH OTHER BUSINESS AS MAY COME BEFORE THE MEETING. REVIEW OF 990 FORM 990 PART VI, LINE 11B COUNT ME IN'S FORM 990 WAS PREPARED WITH THE ASSISTANCE OF THE ORGANIZATION'S AUDITORS, PRICEWATERHOUSECOOPERS LLP. THE FULL BOARD OF DIRECTORS RECEIVED A COMPLETED COPY OF THE FORM 990 PRIOR TO THE FORM BEING FILED WITH THE IRS. CONFLICT OF INTEREST POLICY FORM 990 PART VI, LINE 12C EACH DIRECTOR AND OFFICER HAS A DUTY TO PLACE THE INTEREST OF COUNT ME IN FOREMOST IN ANY DEALING WITH THE ORGANIZATION AND HAS A CONTINUING RESPONSIBILITY TO COMPLY WITH THE REQUIREMENTS OF THIS POLICY. PROMPTLY FOLLOWING THEIR ELECTION OR APPOINTMENT, AND THEREAFTER NOT LATER THAN THE FIRST DAY OF DECEMBER OF EACH YEAR, EACH DIRECTOR AND OFFICER SHALL ACKNOWLEDGE THEIR FAMILIARITY WITH THIS POLICY AND SHALL DISCLOSE IN WRITING TO THE CLERK ANY EXISTING FINANCIAL OR OTHER MATERIAL INTERESTS SUBJECT TO THIS POLICY BY COMPLETING A CONFLICT OF INTEREST DISCLOSURE STATEMENT. THE CONFLICT OF INTEREST DISCLOSURE STATEMENTS SHALL BE REVIEWED BY THE CLERK. ANY ISSUES NOT PREVIOUSLY DISCLOSED SHALL BE REFERRED BY THEM TO THE BOARD OR APPROPRIATE COMMITTEE. THE CONFLICT OF INTEREST DISCLOSURE STATEMENTS SHALL BE RETAINED IN THE CONFIDENTIAL FILES OF THE CLERK. PUBLIC DISCLOSURE OF DOCUMENTS FORM 990 PART VI, LINE 18 THE FORM 990 IS MADE AVAILABLE UPON REQUEST AND ON GUIDESTAR.ORG. THE FORM 1023 IS MADE AVAILABLE UPON REQUEST. AVAILABILITY OF DOCUMENTS FORM 990 PART VI, LINE 19 COUNT ME IN'S AUDITED FINANCIAL STATEMENTS ARE ATTACHED TO THE ANNUALLY FILED MASSACHUSETTS FORM PC, WHICH IS AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE AVAILABLE TO THE PUBLIC UPON REQUEST.